Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Stalled oligodendrocyte differentiation in IDH-mutant gliomas

Fig. 2

Suppressed myelination program in PM gliomas from the CGGA dataset. A Under expression in PM gliomas of the MO marker GALC/O1, myelin components (MBP, MOG), and myelination regulators MYRF/C11ORF9. B Sustained expression of stage-specific markers of pre-OPC and OPC in PM gliomas. C Sustained expression of stage-specific marker of NFOL in PM gliomas. D Co-staining with LFB which labels myelin structures, and with the anti-IDH1 R132H antibody which stains IDH1 mutant cells, of a representative PM glioma with 1p19q co-deletion is shown for tumor (left) and NT (right) regions. Myelin fiber is absent in tumor regions with strong cytosolic staining of the IDH1 R132H mutant protein

Back to article page